[e-drug] 4th Annual Summer Institute in Maternal-Fetal Pharmacology

["Donald Mattison" <mattisod@mail.nih.gov>]

E-DRUG: 4th Annual Summer Institute in Maternal-Fetal Pharmacology
-------------------------------------------------------------------------

We are now accepting applications for the Summer Institute - web page is located at www.cihr-irsc.gc.ca/e/35722.html

The National Institutes of Health and the Canadian Institutes of Health
Research 4th Annual Summer Institute in Maternal-Fetal Pharmacology

July 18-24, 2008
Doubletree Hotel, Burlington, Vermont

The National Institute of Child Health and Human Development (NICHD) and
the Office of Research on Women's Health (ORWH) at the National
Institutes of Health (NIH) and the Institute of Human Development, Child
and Youth Health (IHDCYH) at the Canadian Institutes of Health Research
(CIHR) are pleased to announce their 4th annual Summer Institute in
Maternal-Fetal Pharmacology.

The Institute provides training for clinical and non-clinical scientists
who are considering academic careers in studying therapeutics during
pregnancy, the perinatal period, and lactation. Presently, the pregnant
mother and her unborn infant are rarely included in therapeutic studies,
leading to orphaning from the benefits of drug therapy. The main
objective of the Institute is to foster the development of a critical
mass of researchers in this neglected area.

Course Methods

Up to 20 applicants will be selected and mentored by leading faculty
from American and Canadian Universitities, National Institute of Child
Health and Human Development (NICHD). The course format will encourage
small-group interactions and problem-based learning. The course includes
preparatory work and assignments, which will be sent to participants one
month ahead of time. Each participant will be expected to develop a
preclinical or clinical drug therapy protocol before the course. These
protocols will be discussed in small groups of approximately 7 trainees
and 2 or 3 faculty members, and subsequently by the larger (plenary)
group. Participants will also be encouraged to bring their own protocol
in development for a "Protocol Clinic" with a faculty member who has
expertise and interest in the relevant research area.

The Summer Institute will combine interactive and hands-on learning with
expert lectures. Special focus will be given to interaction between
faculty members and participants.

Faculty members are national and international leaders in various
aspects of obstetric and perinatal pharmacology.

Eligibility and How to Apply

Applicants must be actively engaged in research or enrolled in a formal
research training program, or hold a PhD or a health professional degree
(or equivalent). The health professional degree must be in a field such
as medicine, pharmacy, nursing, pharmacology or toxicology.

For more information on the 4th annual NICHD-IHDCYH Summer Institute in
Maternal-Fetal Pharmacology, please consult the guidelines for
eligibility and the instructions for submitting your application
<http://www.cihr-irsc.gc.ca/e/26729.html> .

The deadline for submission of applications is April 1, 2008.

DHHS and NIH are Equal Opportunity Employers
 

Donald R. Mattison MD, CAPT, US Public Health Service 
Senior Advisor to the Directors of NICHD and CRMC
Branch Chief, Obstetric and Pediatric Pharmacology Branch, CRMC
Eunice Kennedy Shriver National Institute of Child Health and Human
Development
National Institutes of Health, HHS 
Phone 301 451 3823, Fax (301) 480-2897
E-mail: Donald.Mattison@nih.hhs.gov 


Regular mail:
6100 Executive Blvd 
RM 4A01 MSC 7510 
Bethesda MD 20892-7510 
Express mail:
6100 Executive Blvd, RM 4A01 
Rockville MD 20852